Teva Pharmaceutical Industries Ltd.

Director's Dealing • Jun 17, 2025

FORM 44			OMB APPROVAL
Check this box if no longer subject to Section 1166 Form 44 or Form 55 obligations may continue See Instruction 11((b)) Check this box to indicate that a transaction was made pursuant to a contract,, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 1100b55--11((c)) See Instruction 1100 ((Print or Type Responses))	OMB Number:: Estimated average burden hours per response	33223355--00228877 0055
11 Name and Address of Reporting Person ** Kalif Eliyahu Sharon		22 Issuer Name and Ticker or Trading Symbol Teva Pharmaceutical Industries Limited [ TEVA ]	55 Relationship of Reporting Person((s)) to Issuer	((Check all applicable))
((Last)) ((First)) C//O Teva Pharmaceutical Industries Ltd 112244 Dvora HaNevi''a St,,	((Middle))	33 Date of Earliest Transaction ((Month//Day//Year)) 0066//1122//22002255	_ Director X __ Officer ((give title below))	_ 1100%% Owner ___ Other ((specify below)) EVP,, Chief Financial Officer
((Street))		44 If Amendment,, Date Original Filed ((Month//Day//Year))	66 Individual or Joint//Group Filing ((Check Applicable Line)) _ X _ Form filed by One Reporting Person
Tel Aviv,, L33 66994444002200			___ Form filed by More than One Reporting Person

Table I -- Non--Derivative Securities Acquired,, Disposed of,, or Beneficially Owned

((City)) ((State)) ((Zip))

11Title of Security ((Instr 33))	22 Transaction Date ((Month //Day//Year))	22A Deemed Execution Date,, if any ((Month//Day //Year))	33 Transaction Code ((Instr 88))		44 Securities Acquired ((A)) or Disposed of ((D)) ((Instr 33,, 44 and 55))			55 Amount of Securities Beneficially Owned Following Reported Transaction((s)) ((Instr 33 and 44))	66 Ownership Form::	77 Nature of Indirect Beneficial
			Code	V	Amount	((A)) or ((D))	Price		Direct ((D)) or Indirect ((I)) ((Instr 44))	Ownership ((Instr 44))
Ordinary Shares ((11))	0066//1122//22002255		((22)) S		5555,,777755	D	\$\$ 117700776699 ((33))	440033,,228888	D

Table II -- Derivative Securities Acquired,, Disposed of,, or Beneficially Owned (( e..g.. ,, puts,, calls,, warrants,, options,, convertible securities))

11 Title of Derivative Security ((Instr 33))	22 Conversion or Exercise Price of Derivative Security	33 Transaction Date ((Month //Day//Year))	33A Deemed Execution Date,, if any ((Month//Day //Year))	44 Transaction Code ((Instr 88))		55 Number of Derivative Securities Acquired ((A)) or Disposed of ((D)) ((Instr 33,, 44,, and 55))		66 Date Exercisable and Expiration Date ((Month//Day//Year))		77 Title and Amount of Underlying Securities ((Instr 33 and 44))		88 Price of Derivative Security ((Instr 55))	99 Number of Derivative Securities Beneficially	1100 Ownership Form of Derivative Security::	1111 Nature of Indirect Beneficial Ownership ((Instr 44))
				Code	V	((A))	((D))	Date Exercisable Expiration Date			Title Amount or Number of Shares		Owned Following Reported Transaction ((s)) ((Instr 44))	Direct ((D)) or Indirect ((I)) ((Instr 44))

Explanation of Responses::

• 11.. The Ordinary Shares may be represented by American Depositary Shares,, each of which currently represents one Ordinary Share..
• 22.. The transaction reported in this Form 44 was effected pursuant to a Rule 1100b55--11 trading plan adopted by the reporting person on November 2299,, 22002244..
• 33.. The price reported in Column 44 is a weighted average price.. These shares were sold in multiple transactions at prices ranging from \$\$1177..005555 to \$\$1177..1122,, inclusive.. The reporting person undertakes to provide,, upon request by the SEC staff,, the issuer,, or any security holder of the issuer,, full information regarding the number of shares sold at each separate price..

//s// Dov Bergwerk as attorney--in--fact for Eliyahu Sharon Kalif 0066//1166//22002255

Signature of Reporting Person **** Date

Reminder:: Report on a separate line for each class of securities beneficially owned directly or indirectly..

** If the form is filed by more than one reporting person,, see Instruction 44((b))((v))..

**** Intentional misstatements or omissions of facts constitute Federal Criminal Violations.. See 1188 U..S..C.. 11000011 and 1155 U..S..C.. 7788ff((a))..

Note:: File three copies of this Form,, one of which must be manually signed.. If space is insufficient,, see Instruction 66 for procedure..

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number..